We are live on ! Find out more
MD icon

Pediatrix Medical

223 hedge funds and large institutions have $777M invested in Pediatrix Medical in 2023 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 90 increasing their positions, 64 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

867% more call options, than puts

Call options by funds: $261K | Put options by funds: $27K

112% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 17

41% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 64

9% more funds holding

Funds holding: 205223 (+18)

1.72% more ownership

Funds ownership: 97.74%99.46% (+1.7%)

25% less capital invested

Capital invested by funds: $1.04B → $777M (-$265M)

Holders
223
Holders Change
+18
Holders Change %
+8.78%
% of All Funds
3.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
36
Increased
90
Reduced
64
Closed
17
Calls
$261K
Puts
$27K
Net Calls
+$234K
Net Calls Change
-$16K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$126M +$6.74M +651,882 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$96.7M +$239K +23,115 +0.2%
AllianceBernstein
3
AllianceBernstein
Tennessee
$73.3M +$2.28M +220,443 +3%
EARNEST Partners
4
EARNEST Partners
Georgia
$44.8M -$2.93M -283,393 -6%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$41M +$614K +59,336 +1%
State Street
6
State Street
Massachusetts
$31.3M +$1.26M +121,897 +4%
Pacer Advisors
7
Pacer Advisors
Pennsylvania
$30.1M +$18.7M +1,809,828 +127%
Morgan Stanley
8
Morgan Stanley
New York
$25.6M +$20.4M +1,968,865 +252%
Citadel Advisors
9
Citadel Advisors
Florida
$21.2M +$16M +1,543,447 +209%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$20.8M +$5.21M +503,823 +29%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$16.6M +$832K +80,404 +5%
Charles Schwab
12
Charles Schwab
California
$15.2M +$1.54M +148,600 +10%
SBH
13
Segall Bryant & Hamill
Illinois
$14.8M -$1.75M -168,981 -10%
ICM
14
Invenomic Capital Management
Massachusetts
$12.8M +$6.88M +664,955 +93%
Boston Partners
15
Boston Partners
Massachusetts
$12.5M +$13.8M +1,333,180 New
Invesco
16
Invesco
Georgia
$9.49M +$3.26M +315,050 +45%
ACB
17
Aristotle Capital Boston
Massachusetts
$7.67M -$104K -10,019 -1%
Northern Trust
18
Northern Trust
Illinois
$7.65M -$298K -28,780 -3%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$6.9M -$191K -18,483 -2%
ACH
20
ArrowMark Colorado Holdings
Colorado
$6.46M +$791K +76,455 +12%
Norges Bank
21
Norges Bank
Norway
$5.25M -$1.27M -122,890 -18%
SGCIA
22
Smith Graham & Co Investment Advisors
Texas
$4.97M +$1.88M +181,662 +51%
Allianz Asset Management
23
Allianz Asset Management
Germany
$4.96M -$1.12M -108,722 -17%
AQR Capital Management
24
AQR Capital Management
Connecticut
$4.94M -$297K -28,725 -5%
Prudential Financial
25
Prudential Financial
New Jersey
$4.79M +$1.98M +191,854 +59%

MD Hedge Fund Activity: Q4 2023 in Review

223 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2023, worth a combined $777M — down 25% from $1.04B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new MD positions and 17 closed out — a net gain of 19 holders — while 90 added to existing stakes and 64 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $20.4M. The largest seller was Lazard Asset Management, cutting an estimated $84.9M.

  • 223 institutional investors held Pediatrix Medical (MD) as of Q4 2023, up from 205 in Q3 2023.
  • Funds reported $777M of Pediatrix Medical stock for Q4 2023, down 25% quarter-over-quarter.
  • 36 funds opened new Pediatrix Medical positions in Q4 2023 and 17 closed out, a net change of +19 holders.
  • The largest Pediatrix Medical buyer in Q4 2023 was Morgan Stanley, an estimated $20.4M added.
  • The largest Pediatrix Medical seller in Q4 2023 was Lazard Asset Management, an estimated $84.9M sold.

Based on aggregated 13F filings for Q4 2023.